These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 31914953)
1. Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study. Borghs S; Byram L; Chan J; Dedeken P; Logan J; Kiri V; Noack-Rink M; Patsalos PN; Thieffry S BMC Neurol; 2020 Jan; 20(1):7. PubMed ID: 31914953 [TBL] [Abstract][Full Text] [Related]
2. Health care cost associated with the use of enzyme-inducing and non-enzyme-active antiepileptic drugs in the UK: a long-term retrospective matched cohort study. Borghs S; Thieffry S; Noack-Rink M; Dedeken P; Hong LS; Byram L; Logan J; Chan J; Kiri V BMC Neurol; 2017 Mar; 17(1):59. PubMed ID: 28335764 [TBL] [Abstract][Full Text] [Related]
3. Cost-benefit analysis, cost-effectiveness analysis, and impact of antiepileptic drugs on the risk of fracture in patients with epilepsy: A nationwide cohort study. Cheng HH; Kung PT; Wang BR; Chiu LT; Tsai WC Epilepsy Behav; 2020 Feb; 103(Pt A):106851. PubMed ID: 31889639 [TBL] [Abstract][Full Text] [Related]
4. Use of antiepileptic drugs and lipid-lowering agents in the United States. Mintzer S; Maio V; Foley K Epilepsy Behav; 2014 May; 34():105-8. PubMed ID: 24735835 [TBL] [Abstract][Full Text] [Related]
5. Understanding the health economic burden of patients with tuberous sclerosis complex (TSC) with epilepsy: a retrospective cohort study in the UK Clinical Practice Research Datalink (CPRD). Shepherd C; Koepp M; Myland M; Patel K; Miglio C; Siva V; Gray E; Neary M BMJ Open; 2017 Oct; 7(10):e015236. PubMed ID: 28982809 [TBL] [Abstract][Full Text] [Related]
6. Healthcare utilization and costs in children with stable and uncontrolled epilepsy. Cramer JA; Wang ZJ; Chang E; Powers A; Copher R; Cherepanov D; Broder MS Epilepsy Behav; 2014 Mar; 32():135-41. PubMed ID: 24561658 [TBL] [Abstract][Full Text] [Related]
7. Health-care costs and utilization related to long- or short-acting antiepileptic monotherapy use. Cramer JA; Wang ZJ; Chang E; Copher R; Cherepanov D; Broder MS Epilepsy Behav; 2015 Mar; 44():40-6. PubMed ID: 25635369 [TBL] [Abstract][Full Text] [Related]
8. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952 [TBL] [Abstract][Full Text] [Related]
10. Antiepileptic Drug Titration and Related Health Care Resource Use and Costs. Fishman J; Kalilani L; Song Y; Swallow E; Wild I J Manag Care Spec Pharm; 2018 Sep; 24(9):929-938. PubMed ID: 29486142 [TBL] [Abstract][Full Text] [Related]
11. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany. Strzelczyk A; Haag A; Reese JP; Nickolay T; Oertel WH; Dodel R; Knake S; Rosenow F; Hamer HM Epilepsy Behav; 2013 Jun; 27(3):433-8. PubMed ID: 23591262 [TBL] [Abstract][Full Text] [Related]
12. Enzyme-inducing antiepileptic drugs and fractures in people with epilepsy: A systematic review. Fraser LA; Burneo JG; Fraser JA Epilepsy Res; 2015 Oct; 116():59-66. PubMed ID: 26354168 [TBL] [Abstract][Full Text] [Related]
13. Economic impact of epilepsy and the cost of nonadherence to antiepileptic drugs in older Medicare beneficiaries. Ip Q; Malone DC; Chong J; Harris RB; Labiner DM Epilepsy Behav; 2018 Mar; 80():208-214. PubMed ID: 29414554 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population. Davis KL; Candrilli SD; Edin HM Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549 [TBL] [Abstract][Full Text] [Related]
15. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 - A ten-year overview. Willems LM; Richter S; Watermann N; Bauer S; Klein KM; Reese JP; Schöffski O; Hamer HM; Knake S; Rosenow F; Strzelczyk A Epilepsy Behav; 2018 Jun; 83():28-35. PubMed ID: 29649671 [TBL] [Abstract][Full Text] [Related]
16. Lacosamide and concomitant use of antiepileptic and other medications in a US population - A retrospective cohort study. Kalilani L; Lu C; Pierre-Louis B; Gold M Epilepsy Behav; 2017 Jul; 72():51-57. PubMed ID: 28575767 [TBL] [Abstract][Full Text] [Related]
17. Analysis of pooled phase III trials of adjunctive perampanel for epilepsy: Impact of mechanism of action and pharmacokinetics on clinical outcomes. Kwan P; Brodie MJ; Laurenza A; FitzGibbon H; Gidal BE Epilepsy Res; 2015 Nov; 117():117-24. PubMed ID: 26448264 [TBL] [Abstract][Full Text] [Related]
18. Trends in antiepileptic drug treatment and effectiveness in clinical practice in England from 2003 to 2016: a retrospective cohort study using electronic medical records. Powell G; Logan J; Kiri V; Borghs S BMJ Open; 2019 Dec; 9(12):e032551. PubMed ID: 31848168 [TBL] [Abstract][Full Text] [Related]
19. Current state of the union of epilepsy care in the United States: Antiepileptic drugs - An introduction to the Connectors Project. Sirven JI; Shafer PO; Kalilani L; Wild I; Fishman J; Owens S Epilepsy Behav; 2018 Mar; 80():98-103. PubMed ID: 29414565 [TBL] [Abstract][Full Text] [Related]
20. Healthcare utilization and costs in adults with stable and uncontrolled epilepsy. Cramer JA; Wang ZJ; Chang E; Powers A; Copher R; Cherepanov D; Broder MS Epilepsy Behav; 2014 Feb; 31():356-62. PubMed ID: 24239435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]